基于纤维束成像与解剖标志靶向vALIC脑深部电刺激治疗难治性强迫症的对比研究
本研究首次比较基于解剖标志的vALIC脑深部电刺激与基于连接组纤维束成像靶向slMFB的脑深部电刺激治疗难治性强迫症的疗效。纳入20例解剖标志靶向患者与20例纤维束成像靶向患者进行倾向性评分匹配,随访一年。结果显示两组Y-BOCS评分下降无差异,但纤维束成像靶向组刺激相关不良事件更少。
要点
- 两组Y-BOCS评分下降无差异,纤维束成像靶向组应答率65% vs 解剖标志组45%(BF10=1.24)
- 纤维束成像靶向组刺激相关不良事件更少:暂时性38 vs 58例,持续性1 vs 17例(BF10=14.968)
- 抑郁焦虑症状病程、应答时间、参数调整次数及药物使用两组无差异
核心结论
- 基于解剖标志的vALIC脑深部电刺激与基于纤维束成像靶向slMFB的脑深部电刺激对难治性强迫症症状改善程度相当,但纤维束成像靶向组刺激相关不良事件更少。
研究设计与样本
- 本研究纳入20例接受基于解剖标志的vALIC脑深部电刺激的强迫症患者,与20例接受基于纤维束成像靶向slMFB电极植入的患者进行倾向性评分匹配,随访一年比较疗效与安全性。
主要发现
- 两组Y-BOCS评分下降无差异;解剖标志组9例(45%)应答,纤维束成像组13例(65%)应答(BF10=1.24)。
- 抑郁和焦虑症状病程、应答时间、刺激调整次数或药物使用两组无差异。
- 纤维束成像组刺激相关不良事件更少:暂时性不良事件38 vs 58例,持续性不良事件1 vs 17例(BF10=14.968)。
关键数值与推荐
- Y-BOCS评分下降两组无差异;应答率解剖标志组45%(9/20) vs 纤维束成像组65%(13/20),BF10=1.24。
- 刺激相关不良事件:暂时性38 vs 58例,持续性1 vs 17例,BF10=14.968。
临床怎么用
- 对于难治性强迫症患者,纤维束成像靶向slMFB的脑深部电刺激可作为解剖标志靶向vALIC的替代方案,可能减少刺激相关不良事件。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Deep brain stimulation (DBS) of the ventral anterior limb of the internal capsule (vALIC) is effective for refractory obsessive-compulsive disorder (OCD). Retrospective evaluation showed that stimulation closer to the supero-lateral branch of the medial forebrain bundle (slMFB), within the vALIC, was associated with better response to DBS. The present study is the first to compare outcomes of DBS targeted at the vALIC using anatomical landmarks and DBS with connectomic tractography-based targeting of the slMFB. We included 20 OCD-patients with anatomical landmark-based DBS of the vALIC that were propensity score matched to 20 patients with tractography-based targeting of electrodes in the slMFB. After one year, we compared severity of OCD, anxiety and depression symptoms, response rates, time to response, number of parameter adjustments, average current, medication usage and stimulation-related adverse effects. There was no difference in Y-BOCS decrease between patients with anatomical landmark-based and tractography-based DBS. Nine (45%) patients with anatomical landmark-based DBS and 13 (65%) patients with tractography-based DBS were responders (BF10 = 1.24). The course of depression and anxiety symptoms, time to response, number of stimulation adjustments or medication usage did not differ between groups. Patients with tractography-based DBS experienced fewer stimulation-related adverse effects than patients with anatomical landmark-based DBS (38 vs 58 transient and 1 vs. 17 lasting adverse effects; BF10 = 14.968). OCD symptoms in patients with anatomical landmark-based DBS of the vALIC and tractography-based DBS of the slMFB decrease equally, but patients with tractography-based DBS experience less adverse effects.
引用
- Graat I, Mocking RJT, Liebrand LC, et al. Tractography-based versus anatomical landmark-based targeting in vALIC deep brain stimulation for refractory obsessive-compulsive disorder. Mol Psychiatry. 2022. PMID: 36071109. doi:10.1038/s41380-022-01760-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。